June 18, 2020 / 1:26 PM / 19 days ago

BRIEF-Synairgen Announces Expansion Of Placebo-Controlled Home Setting Clinical Trial Of Sng001 In Patients With COVID-19

June 18 (Reuters) - Synairgen PLC:

* SYNAIRGEN PLC - ANNOUNCES EXPANSION OF PLACEBO-CONTROLLED HOME SETTING CLINICAL TRIAL OF SNG001 IN PATIENTS WITH COVID-19

* SYNAIRGEN PLC - TRIAL HAS BEEN EXPANDED BEYOND SOUTHAMPTON AREA TO INCLUDE PATIENTS ACROSS MAJORITY OF UK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below